| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 7 | 0.644 | 0.577 | 2.1E-55 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 2001 | 2020 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2015 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2020 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
group | 0.050 | None | 1.000 | 5 | 1 | 2007 | 2015 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1990 | 2017 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
acetyl-CoA carboxylase beta | 0.644 | 0.654 | 7.6E-47 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
acyl-CoA synthetase family member 3 | 0.743 | 0.308 | 2.3E-26 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 1993 | 2018 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
ADCYAP receptor type I | 0.561 | 0.769 | 7.2E-10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2018 | 2019 | ||||||||
|
adiponectin receptor 1 | 0.529 | 0.808 | 0.66 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2018 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2002 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2005 | 2019 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 2005 | 2018 |